IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $112,000 | +600.0% | 1,315 | +10.5% | 0.00% | – |
| Q2 2020 | $16,000 | 0.0% | 1,190 | 0.0% | 0.00% | – |
| Q1 2020 | $16,000 | -30.4% | 1,190 | +9.1% | 0.00% | – |
| Q4 2019 | $23,000 | +43.8% | 1,091 | -10.1% | 0.00% | – |
| Q3 2019 | $16,000 | -5.9% | 1,214 | 0.0% | 0.00% | – |
| Q2 2019 | $17,000 | -26.1% | 1,214 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | +21.1% | 1,214 | -9.4% | 0.00% | – |
| Q4 2018 | $19,000 | +11.8% | 1,340 | +59.5% | 0.00% | – |
| Q3 2018 | $17,000 | -15.0% | 840 | 0.0% | 0.00% | – |
| Q2 2018 | $20,000 | +66.7% | 840 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | – | 840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
| J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
| Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
| SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
| J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |